科研製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2016/07/14 | 6,960 | 7,140 | 6,880 | 7,040 | +20 | +0.3% | 255,100 |
2016/07/13 | 7,220 | 7,250 | 6,990 | 7,020 | -120 | -1.7% | 363,000 |
2016/07/12 | 7,250 | 7,280 | 7,120 | 7,140 | ±0 | ±0% | 289,100 |
2016/07/11 | 7,060 | 7,170 | 7,030 | 7,140 | +240 | +3.5% | 203,300 |
2016/07/08 | 7,010 | 7,140 | 6,870 | 6,900 | -70 | -1% | 250,800 |
2016/07/07 | 6,970 | 7,010 | 6,900 | 6,970 | +30 | +0.4% | 188,600 |
2016/07/06 | 6,910 | 6,970 | 6,810 | 6,940 | -80 | -1.1% | 285,400 |
2016/07/05 | 7,010 | 7,020 | 6,890 | 7,020 | +40 | +0.6% | 261,000 |
2016/07/04 | 6,940 | 7,010 | 6,900 | 6,980 | +70 | +1% | 189,300 |
2016/07/01 | 6,770 | 6,910 | 6,720 | 6,910 | +220 | +3.3% | 262,100 |
2016/06/30 | 6,650 | 6,780 | 6,560 | 6,690 | +50 | +0.8% | 302,200 |
2016/06/29 | 6,650 | 6,740 | 6,590 | 6,640 | +30 | +0.5% | 181,200 |
2016/06/28 | 6,370 | 6,680 | 6,370 | 6,610 | +50 | +0.8% | 220,200 |
2016/06/27 | 6,350 | 6,630 | 6,350 | 6,560 | +310 | +5% | 266,400 |
2016/06/24 | 6,700 | 6,820 | 6,200 | 6,250 | -480 | -7.1% | 455,400 |
2016/06/23 | 6,700 | 6,790 | 6,690 | 6,730 | +70 | +1.1% | 324,400 |
2016/06/22 | 6,540 | 6,710 | 6,500 | 6,660 | +20 | +0.3% | 318,100 |
2016/06/21 | 6,340 | 6,660 | 6,310 | 6,640 | +240 | +3.8% | 412,500 |
2016/06/20 | 6,340 | 6,420 | 6,290 | 6,400 | +140 | +2.2% | 252,200 |
2016/06/17 | 6,280 | 6,390 | 6,240 | 6,260 | +160 | +2.6% | 486,900 |
2016/06/16 | 6,360 | 6,360 | 6,100 | 6,100 | -350 | -5.4% | 439,800 |
2016/06/15 | 6,210 | 6,500 | 6,210 | 6,450 | +270 | +4.4% | 538,000 |
2016/06/14 | 6,220 | 6,280 | 6,160 | 6,180 | -40 | -0.6% | 302,600 |
2016/06/13 | 6,230 | 6,280 | 6,190 | 6,220 | -110 | -1.7% | 264,900 |
2016/06/10 | 6,380 | 6,380 | 6,290 | 6,330 | +30 | +0.5% | 212,700 |
2016/06/09 | 6,320 | 6,360 | 6,260 | 6,300 | +10 | +0.2% | 262,400 |
2016/06/08 | 6,380 | 6,420 | 6,230 | 6,290 | -130 | -2% | 417,300 |
2016/06/07 | 6,250 | 6,420 | 6,250 | 6,420 | +120 | +1.9% | 221,000 |
2016/06/06 | 6,180 | 6,300 | 6,160 | 6,300 | -10 | -0.2% | 190,000 |
2016/06/03 | 6,300 | 6,350 | 6,260 | 6,310 | +80 | +1.3% | 246,600 |
2016/06/02 | 6,260 | 6,310 | 6,200 | 6,230 | -30 | -0.5% | 244,000 |
2016/06/01 | 6,240 | 6,320 | 6,200 | 6,260 | -30 | -0.5% | 260,500 |
2016/05/31 | 6,300 | 6,320 | 6,260 | 6,290 | +20 | +0.3% | 211,300 |
2016/05/30 | 6,160 | 6,280 | 6,110 | 6,270 | +140 | +2.3% | 145,000 |
2016/05/27 | 6,140 | 6,190 | 6,110 | 6,130 | ±0 | ±0% | 147,400 |
2016/05/26 | 6,180 | 6,190 | 6,110 | 6,130 | +100 | +1.7% | 187,700 |
2016/05/25 | 6,060 | 6,120 | 6,030 | 6,030 | +50 | +0.8% | 189,100 |
2016/05/24 | 5,920 | 5,990 | 5,870 | 5,980 | +50 | +0.8% | 163,700 |
2016/05/23 | 5,850 | 5,930 | 5,800 | 5,930 | +70 | +1.2% | 191,500 |
2016/05/20 | 5,830 | 5,880 | 5,780 | 5,860 | -10 | -0.2% | 221,400 |
2016/05/19 | 5,820 | 5,930 | 5,810 | 5,870 | -40 | -0.7% | 220,200 |
2016/05/18 | 5,880 | 5,980 | 5,850 | 5,910 | +30 | +0.5% | 236,600 |
2016/05/17 | 5,820 | 5,880 | 5,800 | 5,880 | +60 | +1% | 215,500 |
2016/05/16 | 5,940 | 5,960 | 5,800 | 5,820 | -100 | -1.7% | 238,100 |
2016/05/13 | 5,880 | 6,000 | 5,850 | 5,920 | +100 | +1.7% | 500,700 |
2016/05/12 | 6,070 | 6,300 | 5,750 | 5,820 | -260 | -4.3% | 707,400 |
2016/05/11 | 6,100 | 6,170 | 6,010 | 6,080 | +60 | +1% | 311,500 |
2016/05/10 | 5,920 | 6,060 | 5,880 | 6,020 | +160 | +2.7% | 252,900 |
2016/05/09 | 5,810 | 5,890 | 5,730 | 5,860 | +90 | +1.6% | 224,600 |
2016/05/06 | 5,840 | 5,940 | 5,700 | 5,770 | -30 | -0.5% | 544,600 |
2151~
2200
件表示中 / 3693件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
科研薬 | 405,500円 | +30.5% | +111.0% | 4.69% | 11.43倍 | 0.99倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
日本新薬 | 348,400円 | +7.9% | +8.9% | 3.56% | 7.45倍 | 1.00倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
サワイGHD | 201,600円 | +4.0% | +25.4% | 2.63% | 8.82倍 | 1.16倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
キッセイ薬 | 381,000円 | +14.5% | -2.3% | 2.36% | 13.94倍 | 0.74倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
サンバイオ | 231,700円 | - | - | 0.00% | - | 107.32倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム